Humanized virus-suppressing factor inhibits hepatitis B virus infection by targeting viral cell entry

Although nucleos(t)ide analogs and interferons suppress hepatitis B virus (HBV) replication, they must be taken continuously and have a low response rate. Therefore, therapeutics for HBV with novel modes of action are needed. Humanized virus-suppressing factor (hzVSF) is a monoclonal antibody agains...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyakawa, Yu, Otsuka, Motoyuki, Sekiba, Kazuma, Funato, Kazuyoshi, Koike, Kazuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8319007/
https://www.ncbi.nlm.nih.gov/pubmed/34345745
http://dx.doi.org/10.1016/j.heliyon.2021.e07586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8319007/
https://www.ncbi.nlm.nih.gov/pubmed/34345745
http://dx.doi.org/10.1016/j.heliyon.2021.e07586

Ejemplares similares